ESR1 and Insulin resistance: Competitive binding of E3 and E2 to the estrogen receptor and decreased expression of both estrogen receptors in cases of GDM, which coincides with increased leptin expression and the associated increase in pro-inflammatory cytokines (100) may contribute to the development of insulin resistance.